1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 03 NOVEMBER 2014

Cancer Drug News 03 NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Jakavi's Myelofibrosis Monopoly Set To End
Industry Brief - DARA Appeals FDA To Amend Tamoxifen Citrate/Soltamox Label
Industry Brief - Synta Initiates Phase II I-SPY 2 TRIAL Of Ganetespib In BC
Industry Brief - Lannett Gains US Letrozole Approval
Industry Brief - Curis Granted US Patent Allowance Covering HDAC/PI3K-Targeted Compounds
Industry Brief - Kiadis' ATIR Gains ODD In Europe For AML
Industry Brief - Betta Invests USD20mn In Xcovery To Gain Chinese Rights To X-396
Industry Brief - Dosing Begins In Heat Biologics' Phase II Bladder Cancer Trial Of Vesigenurtacel-L
Industry Brief - Xtandi Phase III Trial Initiated In Hormone-Sensitive Non-Metastatic PCA
Industry Brief - Positive Data From Apogenix' APG101 Phase II GBM Trial
Industry Trend Analysis - BMS Fortifies Immuno-Oncology Pipeline With Acquisition Option
Industry Trend Analysis - Next-Generation Antibodies Instigate New Wave Of Collaborations
Industry Brief - 4SC Strengthens Resminostat Patent Protection
Industry Trend Analysis - Ventana Secures Further Companion Diagnostic Partnership
Industry Brief - RaQualia Granted Japanese Patent Allowance For EP4 Antagonist
Industry Brief - Genmab Transfers Ofatumumab Collaboration From GSK To Novartis
Industry Brief - QIAGEN/Astellas Team Up For Developing Companion Diagnostics
Industry Trend Analysis - Oncology Will Be A Major Growth Driver For Amgen
Industry Brief - Celator Raises Funds In Public Share Offering
Industry Brief - Cancer Conferences - February 2015

Table Of Contents

Cancer Drug News 03 NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.